Navigation Links
Alarming new data shows TB-HIV co-infection a bigger threat
Date:3/24/2009

WASHINGTONThe World Health Organization released staggering new data about the threat of tuberculosis and the toll it takes on people with HIV/AIDS today, in recognition of World TB Day.

The TB-HIV co-infection crisis is twice as big as previously thought, the new WHO figures show. In 2007, there were at least 1.37 million cases of HIV-positive TBor nearly 15 percent of the total incident cases. That's double the previous WHO estimates.

"A global health catastrophe is unfolding," said Gerald Friedland, a professor of Medicine, Epidemiology and Public Health at Yale University School of Medicine and a leading expert on the emerging threat.

In addition, the WHO data shows that drug-resistant TB is on the rise. There were more than 500,000 cases of MDR-TB in 2007, the WHO reported. And by the end of 2008, at least 55 countries and territories had identified at least one case of extensively drug-resistant TB.

In light of the new WHO figures and increasing concern about the threat of drug-resistant TB, leading physicians and scientists are urging the Obama administration to triple the U.S. donation to the Global Fund to Fight AIDS, Tuberculosis and Malaria and to dramatically ramp up the U.S.'s own vastly-underfunded global TB programs.

Right now, nearly 60 countries are seeking new Global Fund grants for anti-TB programs. But the Fund, facing a $5 billion donation shortfall, may not be able to finance any of these desperately needed efforts.

Five world-renown experts on TB and HIV are available to discuss the new WHO dataset to be released on March 24th, World TB Day. They can address the scope of the TB-HIV co-infection crisis and talk about how U.S. policy makers should respond.

Tuberculosis is sometimes a forgotten and neglected disease. But an estimated one-third of the world's population is infected with the bacterium that causes TB, and the disease kills nearly 1.7 million people each year.

Now, virulent new drug-resistant strains of TB are on the rise across the globe. HIV-positive patients are highly vulnerable to TB, because of their weakened immune systems, and tuberculosis is now the No. 1 killer of people with HIV.

These twin epidemics present a stark new global health threat and raise the prospect of a global pandemic of extensively-drug-resistant TB, which is extremely difficult to treat.

The new WHO figures come amid deep concern among global health advocates that the Obama administration will flatline vital HIV/AIDS and TB programs, as the global recession deepens. The president is expected to release his detailed request for global health and other programs in the coming weeks. Advocates are urging full funding for PEPFAR, so the initiative can tackle the growing crisis of HIV-TB co-infection, and a tripling of the U.S. contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria.


'/>"/>

Contact: Deirde Shesgreen
dshesgreen@idsociety.org
703-740-4954
Infectious Diseases Society of America
Source:Eurekalert

Related medicine news :

1. Astronauts on International Space Station lose alarming amounts of hipbone strength
2. New Asia Pacific Statistics Reveal an Alarming Incidence of HIV in MSM
3. Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital-Acquired Infections
4. New Trend Data Shows Access to Surgical Care at Risk in Rural and Urban Areas of the United States
5. Study shows how Salmonella survives in environment
6. Research Shows that Weekend Binge Drinking Can Lead to Parents Drink Driving - Warns the Linwood Group
7. New Parkinsons Treatment Shows Promise in Animals
8. Research shows biopsy of recurrent breast cancer can alter treatment
9. US trial shows no early mortality benefit from annual prostate cancer screening
10. Spinal taps carry higher risks for infants and elderly, study shows
11. Important new model shows how proteins find the right DNA sequences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the ... analysis system called the HORIZON at MIBio 2017 in ... subvisible and visible particulate matter in biopharmaceutical samples with unprecedented speed ... of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: